Evidence map›Paper›PMID 34601231›Full record

ArticleMedical hypotheses2021

Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection.

Anubhuti Sood, Sreevatsan Raghavan, Puneet Batra, Karan Sharma, Aditya Talwar

Open access · greenAbstract read
In one paragraph

Article in Medical hypotheses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Lichen planus after COVID-19 infection and vaccination.Archives of dermatological research · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Anubhuti SoodClinical Development Services Agency, Translational Health Science and Technology Institute (THSTI), Faridabad, Haryana, 121001, India. Electronic address: dr.anu88.18@gmail.com.
Sreevatsan RaghavanPrivate Practitioner, Noida, Uttar Pradesh, 201307, India.
Puneet BatraMOrth, RCS Edin, Director-PG Studies, Manav Rachna Dental College, Faridabad, Haryana, India.
Karan SharmaPrivate Practitioner, Delhi, India.
Aditya TalwarDepartment of Orthodontics, Manav Rachna Dental College, Faridabad, Haryana, India.
Manav Rachna International Institute of Research and Studies · INTranslational Health Science and Technology Institute · INVigyan Prasar · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral Lichen Planus (OLP) is a chronic inflammatory disorder whose exact etiology remains unknown. Inflammatory mediators, cytotoxic CD8+ T cells and mast cells have been hypothesized to mediate the pathogenesis of OLP. COVID-19 pandemic caused by SARS-CoV-2 is marked by cytokine storms in the affected patients. Altered T-cell responses marked by exhaustion of T-cell count with hyperaggressive remaining T-cells and presence of cross-reactive antibodies render infected humans as fertile grounds for development of multisystem disorders. In addition, Vitamin D deficiency in COVID-19 patients can further modify the T cell mediated immunity. Increased circulating cytokines and hyperactive CD8+ T cells can alter the oral immune barriers rendering them susceptible to oral disorders. Due to the widespread immune dysregulation, it is possible that patients of COVID-19 may develop OLP in the aftermath or during recovery. The paper explores the pathogenic mechanism behind development OLP as post-COVID condition on account of their target receptor, T-cell responses, cytokine profile, mucosal immune barriers and nutrition deficiency.

Indexed as

COVID-19Lichen Planus, OralCD8-Positive T-LymphocytesHumansPandemicsSARS-CoV-2COVID-19Oral lichen planusPost-COVID complicationSARS-CoV-2

Identifiers

PMID34601231
PMCPMC8478127
OpenAlexW3201138688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.